2021-02-22
Published Date
Life Science
Industry
90
Pages
The latest study on Congenital Heart Disease Market by Read Market Research provides a detailed summary and overview of the global market. The base year considered in this report is considered 2020 whereas information for 2021 is estimated and forecast from 2022 till 2027. The CAGR (Compound Annual Growth Rate) period of this report is 2021-2027. The Global Congenital Heart Disease Market is valued at USD XX Million in the year 2020 and is estimated to grow at USD XX Million by the end of year 2027.The report will shed light on very important growth aspect of Congenital Heart Disease and is a must have data for all the companies, investors, decision makers, top level executives and readers.
The segmental analysis of the report provides detailed analysis on Revenue, Growth, Forecast By Region, Type and Applications for the period 2016-2027.
The major vendors covered:
Abbott Diagnostics
Array BioPharma
AstraZeneca
Becton Dickinson
BG Medicine
Bio-Rad
Boston Scientific
Covance
Critical Diagnostics
Roche
GSK
Janssen Pharmaceuticals
Medtronic
Merck
Mylan
Congenital Heart Disease Market Analysis By Type Segment:
Medications
Implantable heart devices
Catheter procedures
Open-heart surgery
Heart transplant
Congenital Heart Disease Market Analysis By Application Segment:
Hospitals and clinics
Diagnostic centres
Congenital Heart Disease Market Analysis By Regions (Countries):
The Congenital Heart Disease Market has been thoroughly researched with the help of Primary and Secondary Research and has been validated by conduction interviews with industry experts across all the regions. As it is global study, we have included all the major regions.
Bottom Up approach has been used to derive and define the market size and shares of regions. Regions such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc. has been taken into consideration while deriving the market size and shares of regions.
Key Details of Regions and Countries of Congenital Heart Disease Report:
North America
United States
Canada
Mexico
Europe
Germany
France
UK
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
Indonesia
Thailand
Malaysia
Philippines
Vietnam
Central & South America
Brazil
Middle East & Africa
Turkey
GCC Countries
Egypt
South Africa
Key data provided:
Market Size of Regions
Market Share of Regions
Compound Annual Growth Rate (CAGR)
Historic Data From 2016-2020
Forecast Data From 2021-2027
Competitive Landscape of Congenital Heart Disease Market:
Congenital Heart Disease market competitive landscape analysis sheds light on the current market structure by players. The report will help the readers to understand some most important questions of the global market.
Key Questions Answered in Competitive Landscape-
List of Key Players
Revenue By players
Market share of players
Product Offerings
The study objectives are:
To analyze and research the Congenital Heart Disease Market status and future forecast.
To present the key Congenital Heart Disease Market analysis of companies and present revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
Table of Contents
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Congenital Heart Disease Market Size Growth Rate by Type (2016-2027)
1.4.2 Medications
1.4.3 Implantable heart devices
1.4.4 Catheter procedures
1.4.5 Open-heart surgery
1.4.6 Heart transplant
1.5 Market by Application
1.5.1 Global Congenital Heart Disease Market Share by Application (2016-2027)
1.5.2 Hospitals and clinics
1.5.3 Diagnostic centres
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Congenital Heart Disease Market Size
2.2 Congenital Heart Disease Growth Trends by Regions
2.2.1 Congenital Heart Disease Market Size by Regions (2016-2027)
2.2.2 Congenital Heart Disease Market Share by Regions (2016-2020)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Opportunities
3 Market Share by Key Players
3.1 Congenital Heart Disease Market Size by Manufacturers
3.1.1 Global Congenital Heart Disease Revenue by Manufacturers (2020)
3.1.2 Global Congenital Heart Disease Revenue Market Share by Manufacturers (2020)
3.1.3 Global Congenital Heart Disease Market Concentration Ratio (CR5 and HHI)
3.2 Congenital Heart Disease Key Players Head office and Area Served
3.3 Key Players Congenital Heart Disease Product/Solution/Service
3.4 Date of Enter into Congenital Heart Disease Market
3.5 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type and Application
4.1 Global Congenital Heart Disease Market Size by Type (2016-2020)
4.2 Global Congenital Heart Disease Market Size by Application (2016-2020)
5 United States
5.1 United States Congenital Heart Disease Market Size (2016-2020)
5.2 Congenital Heart Disease Key Players in United States
5.3 United States Congenital Heart Disease Market Size by Type
5.4 United States Congenital Heart Disease Market Size by Application
6 Europe
6.1 Europe Congenital Heart Disease Market Size (2016-2020)
6.2 Congenital Heart Disease Key Players in Europe
6.3 Europe Congenital Heart Disease Market Size by Type
6.4 Europe Congenital Heart Disease Market Size by Application
7 China
7.1 China Congenital Heart Disease Market Size (2016-2020)
7.2 Congenital Heart Disease Key Players in China
7.3 China Congenital Heart Disease Market Size by Type
7.4 China Congenital Heart Disease Market Size by Application
8 Japan
8.1 Japan Congenital Heart Disease Market Size (2016-2020)
8.2 Congenital Heart Disease Key Players in Japan
8.3 Japan Congenital Heart Disease Market Size by Type
8.4 Japan Congenital Heart Disease Market Size by Application
9 Southeast Asia
9.1 Southeast Asia Congenital Heart Disease Market Size (2016-2020)
9.2 Congenital Heart Disease Key Players in Southeast Asia
9.3 Southeast Asia Congenital Heart Disease Market Size by Type
9.4 Southeast Asia Congenital Heart Disease Market Size by Application
10 India
10.1 India Congenital Heart Disease Market Size (2016-2020)
10.2 Congenital Heart Disease Key Players in India
10.3 India Congenital Heart Disease Market Size by Type
10.4 India Congenital Heart Disease Market Size by Application
11 Central & South America
11.1 Central & South America Congenital Heart Disease Market Size (2016-2020)
11.2 Congenital Heart Disease Key Players in Central & South America
11.3 Central & South America Congenital Heart Disease Market Size by Type
11.4 Central & South America Congenital Heart Disease Market Size by Application
12 International Players Profiles
12.1 Abbott Diagnostics
12.1.1 Abbott Diagnostics Company Details
12.1.2 Company Description and Business Overview
12.1.3 Congenital Heart Disease Introduction
12.1.4 Abbott Diagnostics Revenue in Congenital Heart Disease Business (2020)
12.1.5 Abbott Diagnostics Recent Development
12.2 Array BioPharma
12.2.1 Array BioPharma Company Details
12.2.2 Company Description and Business Overview
12.2.3 Congenital Heart Disease Introduction
12.2.4 Array BioPharma Revenue in Congenital Heart Disease Business (2020)
12.2.5 Array BioPharma Recent Development
12.3 AstraZeneca
12.3.1 AstraZeneca Company Details
12.3.2 Company Description and Business Overview
12.3.3 Congenital Heart Disease Introduction
12.3.4 AstraZeneca Revenue in Congenital Heart Disease Business (2020)
12.3.5 AstraZeneca Recent Development
12.4 Becton Dickinson
12.4.1 Becton Dickinson Company Details
12.4.2 Company Description and Business Overview
12.4.3 Congenital Heart Disease Introduction
12.4.4 Becton Dickinson Revenue in Congenital Heart Disease Business (2020)
12.4.5 Becton Dickinson Recent Development
12.5 BG Medicine
12.5.1 BG Medicine Company Details
12.5.2 Company Description and Business Overview
12.5.3 Congenital Heart Disease Introduction
12.5.4 BG Medicine Revenue in Congenital Heart Disease Business (2020)
12.5.5 BG Medicine Recent Development
12.6 Bio-Rad
12.6.1 Bio-Rad Company Details
12.6.2 Company Description and Business Overview
12.6.3 Congenital Heart Disease Introduction
12.6.4 Bio-Rad Revenue in Congenital Heart Disease Business (2020)
12.6.5 Bio-Rad Recent Development
12.7 Boston Scientific
12.7.1 Boston Scientific Company Details
12.7.2 Company Description and Business Overview
12.7.3 Congenital Heart Disease Introduction
12.7.4 Boston Scientific Revenue in Congenital Heart Disease Business (2020)
12.7.5 Boston Scientific Recent Development
12.8 Covance
12.8.1 Covance Company Details
12.8.2 Company Description and Business Overview
12.8.3 Congenital Heart Disease Introduction
12.8.4 Covance Revenue in Congenital Heart Disease Business (2020)
12.8.5 Covance Recent Development
12.9 Critical Diagnostics
12.9.1 Critical Diagnostics Company Details
12.9.2 Company Description and Business Overview
12.9.3 Congenital Heart Disease Introduction
12.9.4 Critical Diagnostics Revenue in Congenital Heart Disease Business (2020)
12.9.5 Critical Diagnostics Recent Development
12.10 Roche
12.10.1 Roche Company Details
12.10.2 Company Description and Business Overview
12.10.3 Congenital Heart Disease Introduction
12.10.4 Roche Revenue in Congenital Heart Disease Business (2020)
12.10.5 Roche Recent Development
12.11 GSK
12.12 Janssen Pharmaceuticals
12.13 Medtronic
12.14 Merck
12.15 Mylan
13 Market Forecast 2021-2027
13.1 Market Size Forecast by Regions
13.2 United States
13.3 Europe
13.4 China
13.5 Japan
13.6 Southeast Asia
13.7 India
13.8 Central & South America
13.9 Market Size Forecast by Product (2021-2027)
13.10 Market Size Forecast by Application (2021-2027)
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
List of Tables and Figures
List of Tables and Figures
Table Congenital Heart Disease Key Market Segments
Table Key Players Congenital Heart Disease Covered
Table Global Congenital Heart Disease Market Size Growth Rate by Type 2016-2027 (Million US$)
Figure Global Congenital Heart Disease Market Size Market Share by Type 2016-2027
Figure Medications Figures
Table Key Players of Medications
Figure Implantable heart devices Figures
Table Key Players of Implantable heart devices
Figure Catheter procedures Figures
Table Key Players of Catheter procedures
Figure Open-heart surgery Figures
Table Key Players of Open-heart surgery
Figure Heart transplant Figures
Table Key Players of Heart transplant
Table Global Congenital Heart Disease Market Size Growth by Application 2016-2027 (Million US$)
Figure Hospitals and clinics Case Studies
Figure Diagnostic centres Case Studies
Figure Congenital Heart Disease Report Years Considered
Table Global Congenital Heart Disease Market Size 2016-2027 (Million US$)
Figure Global Congenital Heart Disease Market Size and Growth Rate 2016-2027 (Million US$)
Table Global Congenital Heart Disease Market Size by Regions 2016-2027 (Million US$)
Table Global Congenital Heart Disease Market Size by Regions 2016-2020 (Million US$)
Table Global Congenital Heart Disease Market Share by Regions 2016-2020
Figure Global Congenital Heart Disease Market Share by Regions 2016-2020
Figure Global Congenital Heart Disease Market Share by Regions 2020
Table Market Top Trends
Table Global Congenital Heart Disease Revenue by Manufacturers (2020) (Million US$)
Table Global Congenital Heart Disease Market Share by Manufacturers (2020)
Figure Global Congenital Heart Disease Market Share by Manufacturers in 2020
Table Global Congenital Heart Disease Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Players Head office and Area Served
Table Key Players Congenital Heart Disease Product/Solution/Service
Table Date of Enter into Congenital Heart Disease Market
Table Mergers & Acquisitions, Expansion Plans
Table Global Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table Global Congenital Heart Disease Market Size Share by Type (2016-2020)
Figure Global Congenital Heart Disease Market Size Market Share by Type (2016-2020)
Table Global Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table Global Congenital Heart Disease Market Size Share by Application (2016-2020)
Figure Global Congenital Heart Disease Market Size Market Share by Application (2016-2020)
Figure Global Congenital Heart Disease Revenue Market Share by Application in 2020
Figure United States Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table United States Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table United States Key Players Congenital Heart Disease Market Share (2020)
Table United States Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table United States Congenital Heart Disease Market Share by Type (2016-2020)
Table United States Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table United States Congenital Heart Disease Market Share by Application (2016-2020)
Figure Europe Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table Europe Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table Europe Key Players Congenital Heart Disease Market Share (2020)
Table Europe Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table Europe Congenital Heart Disease Market Share by Type (2016-2020)
Table Europe Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table Europe Congenital Heart Disease Market Share by Application (2016-2020)
Figure China Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table China Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table China Key Players Congenital Heart Disease Market Share (2020)
Table China Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table China Congenital Heart Disease Market Share by Type (2016-2020)
Table China Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table China Congenital Heart Disease Market Share by Application (2016-2020)
Figure Japan Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table Japan Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table Japan Key Players Congenital Heart Disease Market Share (2020)
Table Japan Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table Japan Congenital Heart Disease Market Share by Type (2016-2020)
Table Japan Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table Japan Congenital Heart Disease Market Share by Application (2016-2020)
Figure Southeast Asia Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table Southeast Asia Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table Southeast Asia Key Players Congenital Heart Disease Market Share (2020)
Table Southeast Asia Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table Southeast Asia Congenital Heart Disease Market Share by Type (2016-2020)
Table Southeast Asia Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table Southeast Asia Congenital Heart Disease Market Share by Application (2016-2020)
Figure India Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table India Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table India Key Players Congenital Heart Disease Market Share (2020)
Table India Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table India Congenital Heart Disease Market Share by Type (2016-2020)
Table India Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table India Congenital Heart Disease Market Share by Application (2016-2020)
Figure Central & South America Congenital Heart Disease Market Size 2016-2020 (Million US$)
Table Central & South America Key Players Congenital Heart Disease Revenue (2020) (Million US$)
Table Central & South America Key Players Congenital Heart Disease Market Share (2020)
Table Central & South America Congenital Heart Disease Market Size by Type (2016-2020) (Million US$)
Table Central & South America Congenital Heart Disease Market Share by Type (2016-2020)
Table Central & South America Congenital Heart Disease Market Size by Application (2016-2020) (Million US$)
Table Central & South America Congenital Heart Disease Market Share by Application (2016-2020)
Table Abbott Diagnostics Company Details
Table Abbott Diagnostics Revenue in Congenital Heart Disease Business (2020) (Million US$)
Figure Abbott Diagnostics Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Abbott Diagnostics Recent Development
Table Array BioPharma Company Details
Table Array BioPharma Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Array BioPharma Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Array BioPharma Recent Development
Table AstraZeneca Company Details
Table AstraZeneca Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure AstraZeneca Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table AstraZeneca Recent Development
Table Becton Dickinson Company Details
Table Becton Dickinson Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Becton Dickinson Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Becton Dickinson Recent Development
Table BG Medicine Company Details
Table BG Medicine Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure BG Medicine Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table BG Medicine Recent Development
Table Bio-Rad Company Details
Table Bio-Rad Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Bio-Rad Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Bio-Rad Recent Development
Table Boston Scientific Company Details
Table Boston Scientific Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Boston Scientific Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Boston Scientific Recent Development
Table Covance Company Details
Table Covance Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Covance Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Covance Recent Development
Table Critical Diagnostics Company Details
Table Critical Diagnostics Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Critical Diagnostics Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Critical Diagnostics Recent Development
Table Roche Company Details
Table Roche Revenue in Congenital Heart Disease Business (2020)(Million US$)
Figure Roche Revenue Growth Rate in Congenital Heart Disease Business (2020)
Table Roche Recent Development
Table GSK Company Details
Table Janssen Pharmaceuticals Company Details
Table Medtronic Company Details
Table Merck Company Details
Table Mylan Company Details
Table Global Congenital Heart Disease Market Size by Regions (Million US$) 2021-2027
Figure Global Congenital Heart Disease Market Size Share by Regions (2021-2027)
Figure Global Congenital Heart Disease Market Size Share by Regions in 2027
Figure United States Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Figure Europe Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Figure China Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Figure Japan Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Figure Southeast Asia Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Figure India Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Figure Central & South America Congenital Heart Disease Market Size Forecast (2021-2027)(Million USD)
Table Global Congenital Heart Disease Market Size by Product (2021-2027) (Million US$)
Figure Global Congenital Heart Disease Market Size by Product (2021-2027)
Figure Global Congenital Heart Disease Market Size by Product in 2027
Table Global Congenital Heart Disease Market Size by Application (2021-2027) (Million US$)
Figure Global Congenital Heart Disease Market Size by Application (2021-2027)
Figure Global Congenital Heart Disease Market Size by Application in 2027
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources